These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26082135)

  • 1. Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes.
    Dalm D; Galaz-Montoya JG; Miller JL; Grushin K; Villalobos A; Koyfman AY; Schmid MF; Stoilova-McPhie S
    Sci Rep; 2015 Jun; 5():11212. PubMed ID: 26082135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helical organization of blood coagulation factor VIII on lipid nanotubes.
    Miller J; Dalm D; Koyfman AY; Grushin K; Stoilova-McPhie S
    J Vis Exp; 2014 Jun; (88):. PubMed ID: 24961276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain organization of membrane-bound factor VIII.
    Stoilova-McPhie S; Lynch GC; Ludtke S; Pettitt BM
    Biopolymers; 2013 Jul; 99(7):448-59. PubMed ID: 23616213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryo-electron microscopy of coagulation Factor VIII bound to lipid nanotubes.
    Parmenter CD; Cane MC; Zhang R; Stoilova-McPhie S
    Biochem Biophys Res Commun; 2008 Feb; 366(2):288-93. PubMed ID: 18039465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII organisation on nanodiscs with different lipid composition.
    Grushin K; Miller J; Dalm D; Stoilova-McPhie S
    Thromb Haemost; 2015 Apr; 113(4):741-9. PubMed ID: 25589466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography.
    Stoilova-McPhie S; Villoutreix BO; Mertens K; Kemball-Cook G; Holzenburg A
    Blood; 2002 Feb; 99(4):1215-23. PubMed ID: 11830468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of recombinant human coagulation factor VIII to lipid nanotubes.
    Parmenter CD; Stoilova-McPhie S
    FEBS Lett; 2008 May; 582(12):1657-60. PubMed ID: 18435924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
    Fang H; Zögg T; Brandstetter H
    FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of recombinant factor VIII B-domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII.
    Grushin K; Miller J; Dalm D; Parker ET; Healey JF; Lollar P; Stoilova-McPhie S
    Haemophilia; 2014 Sep; 20(5):723-31. PubMed ID: 24750465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of Factor VIII to Lipid Nanodiscs Increases its Clotting Function in a Mouse Model of Hemophilia A.
    Csencsits-Smith K; Grushin K; Stoilova-McPhie S
    J Blood Disord Transfus; 2015 Dec; 6(6):325. PubMed ID: 28936365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
    Duffy EJ; Parker ET; Mutucumarana VP; Johnson AE; Lollar P
    J Biol Chem; 1992 Aug; 267(24):17006-11. PubMed ID: 1512239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII and Factor V Membrane Bound Complexes.
    Stoilova-McPhie S
    Subcell Biochem; 2021; 96():153-175. PubMed ID: 33252728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX.
    Bloem E; Meems H; van den Biggelaar M; Mertens K; Meijer AB
    J Biol Chem; 2013 Sep; 288(36):26105-26111. PubMed ID: 23884417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tertiary structure and domain organization of coagulation factor VIII.
    Shen BW; Spiegel PC; Chang CH; Huh JW; Lee JS; Kim J; Kim YH; Stoddard BL
    Blood; 2008 Feb; 111(3):1240-7. PubMed ID: 17965321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen-Deuterium Exchange Mass Spectrometry Identifies Activated Factor IX-Induced molecular Changes in Activated Factor VIII.
    van Galen J; Freato N; Przeradzka MA; Ebberink EHTM; Boon-Spijker M; van der Zwaan C; van den Biggelaar M; Meijer AB
    Thromb Haemost; 2021 May; 121(5):594-602. PubMed ID: 33302303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of factor VIII by factor IXa.
    O'Brien DP; Johnson D; Byfield P; Tuddenham EG
    Biochemistry; 1992 Mar; 31(10):2805-12. PubMed ID: 1547220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
    Li X; Gabriel DA
    Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential.
    Nakajima Y; Takeyama M; Oda A; Shimonishi N; Nogami K
    Blood Adv; 2023 Apr; 7(8):1436-1445. PubMed ID: 36322904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane Interaction of the Factor VIIIa Discoidin Domains in Atomistic Detail.
    Madsen JJ; Ohkubo YZ; Peters GH; Faber JH; Tajkhorshid E; Olsen OH
    Biochemistry; 2015 Oct; 54(39):6123-31. PubMed ID: 26346528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers.
    Stoylova SS; Lenting PJ; Kemball-Cook G; Holzenburg A
    J Biol Chem; 1999 Dec; 274(51):36573-8. PubMed ID: 10593957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.